Skip to content

Clinical trials

Completed Phase 1 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 1 Status: Completed Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20062
20092
20101
20111
20124
20132
20143
20157
20161
20173
20184
20198
20205
20215
20223
20233
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Assembly Biosciences4
Dynavax Technologies Corporation4
Gilead Sciences4
Enanta Pharmaceuticals, Inc3
Alios Biopharma Inc.2
Dong-A ST Co., Ltd.2
Novira Therapeutics, Inc.2
Albert B. Sabin Vaccine Institute1
Altimmune, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B61
Hepatitis B, Chronic14
Hepatitis5
Virus Diseases4
Hepatitis C3
Liver Diseases3
Communicable Diseases2
Fibrosis2
Infections2
Kidney Failure, Chronic2

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.